Le Lézard
Classified in: Health
Subjects: NPT, SVY, LEG, AVO

New Poll Shows Atlanta Voters Overwhelmingly Support Smoke-free Law


ATLANTA, Oct. 18, 2017 /PRNewswire-USNewswire/ -- A new poll shows overwhelming support among Atlanta voters for a comprehensive smoke-free law that guarantees everyone the right to breathe clean air. Three-quarters of voters (76 percent) favor a law to prohibit smoking inside most public places ? including workplaces, public buildings, offices, restaurants, bars and the Hartsfield-Jackson airport ? including two-thirds of voters (67 percent) who strongly favor the proposed law.

Voters undeniably see secondhand smoke as a health hazard. Some 90 percent say it is a serious or moderate health hazard, including 75 percent who say it is a serious health hazard. The need for protection from secondhand smoke in all workplaces and public places has never been clearer.

"Voters know that secondhand smoke is a health hazard, and this poll shows that they want a strong law protecting their right to breathe clean air," said Andy Freeman, Georgia Government Relations Director, American Cancer Society Cancer Action Network. "While we safeguard our office workers from secondhand smoke, we still leave workers in bars, restaurants and our airport unprotected. We need to ensure that no workers are left behind when it comes to their health. The City Council should listen to the people of Atlanta and act quickly to make all workplaces smoke-free."

"Secondhand smoke is harmful to everyone, and everyone should be protected from it," said June Deen, Senior Vice President of Public Policy and Health Promotions, American Lung Association of the Southeast. "No waitress waiter or bartender should have to choose between health and a paycheck. These hospitality workers have the fewest workplace protections, and that needs to change. It is a matter of fairness ? everyone should have the right to breathe clean air at work ? period."

"The link between secondhand smoke and cardiovascular disease is clear," said Michael Cortes, Government Relations Director at the Metro Atlanta American Heart Association. "Over 22,000 premature deaths from heart and blood vessel disease are caused by other people's smoke each year. Exposure to secondhand smoke can increase the risk of heart disease and stroke by 20 to 30 percent."

The citywide survey of 500 likely 2018 voters was conducted by Lake Research Partners (August 15-20) and released today by the Smoke-Free Atlanta Coalition.

Among the other poll findings:

The Smoke-Free Atlanta Campaign aims to educate the public about the dangers of secondhand smoke and campaign for comprehensive smoke-free workplaces in Atlanta.

Lake Research Partners designed and administered this survey that was conducted by professional interviewers from August 15-20, 2017.The survey reached a total of 500 likely 2018 voters in Atlanta, Georgia. Telephone numbers were drawn from a voter file sample. The margin of error for the sample is +/-4.4%.

 

SOURCE The Smoke-Free Atlanta Campaign


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: